Hal Wolf named new president, CEO of HIMSS

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
 - Hal Wolf HIMSS
Harold "Hal" Wolf III

The Healthcare Information and Management Systems Society (HIMSS) has selected Harold “Hal” Wolf III, an alum of the Chartis Group and Kaiser Permanente, as its new president and CEO.

Wolf’s most recent title has been director of information and digital health strategy at Chartis. His resume also includes a nine-year stint at Kaiser in several different roles, including chief operating officer of its Permanente Foundation and regional CIO for its Colorado facilities. He’s no stranger to HIMSS members, as he’s served as both an advisor to and member of its board and its vice chair for 2016-17.

“It is a great privilege and honor to be chosen to lead HIMSS, an organization whose purpose is to improve healthcare and care outcomes, Wolf said in a statement. “Across the globe, healthcare is challenged to harness the power of information and technology, to solve for the unique environments of each health system and to support the personalization of care to the individual. In alliance with the growing membership of HIMSS and the expansive capabilities of our organization, our collective task is to enable innovation across the full healthcare ecosystem.”

Wolf will be taking the reins from longtime HIMSS leader Stephen Lieber, who announced last year he would retire from the 65,000-member trade group after a 17-year stint as president and CEO. He’ll stay on through the end of the year, with Wolf starting with HIMSS in September before assuming full leadership duties sometime in December.

“Hal Wolf brings to his new role as president and CEO of HIMSS the powerful combination of broad, deep and relevant knowledge, expertise, experience, energy and accomplishments, along with a deep love of and longstanding commitment to HIMSS. His track record of innovation and success spans premier healthcare delivery organizations, digital strategy groups, media companies, global endeavors and more,” said HIMSS board chair Michael Zaroukian, MD, PhD.